Repligen - 39 Year Stock Price History | RGEN

Historical daily share price chart and data for Repligen since 1986 adjusted for splits and dividends. The latest closing stock price for Repligen as of September 02, 2025 is 120.69.
  • The all-time high Repligen stock closing price was 324.21 on September 23, 2021.
  • The Repligen 52-week high stock price is 182.52, which is 51.2% above the current share price.
  • The Repligen 52-week low stock price is 102.97, which is 14.7% below the current share price.
  • The average Repligen stock price for the last 52 weeks is 138.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Repligen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 135.3407 143.0500 174.2400 108.8900 120.6900 -16.15%
2024 158.1179 179.2900 208.4200 119.7900 143.9400 -19.94%
2023 164.4373 162.0000 198.1000 114.1700 179.8000 6.20%
2022 185.2841 257.9600 257.9600 140.6800 169.3100 -36.07%
2021 231.7020 190.6600 324.2100 165.8700 264.8400 38.20%
2020 135.1351 93.7800 206.5700 84.9600 191.6300 107.17%
2019 74.5097 51.6900 95.5100 49.4500 92.5000 75.39%
2018 46.6978 37.0600 68.8800 30.9200 52.7400 45.37%
2017 36.9658 31.1500 46.0600 28.8200 36.2800 17.72%
2016 27.8137 28.1000 33.9800 20.9300 30.8200 8.94%
2015 31.9389 20.1000 42.1400 19.8600 28.2900 42.88%
2014 18.9447 12.6300 25.4900 12.3000 19.8000 45.16%
2013 9.2758 6.6300 13.6400 5.9800 13.6400 117.20%
2012 4.9963 3.5000 7.2600 3.4200 6.2800 80.98%
2011 3.7511 4.5200 5.3400 3.1100 3.4700 -26.01%
2010 3.5501 4.0400 4.7500 3.1300 4.6900 14.11%
2009 4.6106 3.9200 5.5500 3.5600 4.1100 8.73%
2008 5.0503 6.6500 6.8600 3.3000 3.7800 -42.29%
2007 3.9288 2.8000 6.5500 2.8000 6.5500 133.10%
2006 3.3185 3.9000 4.9900 2.2700 2.8100 -29.75%
2005 2.5935 2.9000 4.0000 1.6700 4.0000 38.89%
2004 2.4385 4.1600 4.1600 1.3200 2.8800 -34.10%
2003 5.1839 2.9700 8.2610 2.7600 4.3700 43.75%
2002 2.7860 2.6900 4.3800 2.1100 3.0400 24.79%
2001 2.8077 3.5625 5.6563 1.3400 2.4360 -27.82%
2000 6.6204 3.0625 16.6250 3.0000 3.3750 8.00%
1999 2.7659 1.3750 4.7500 1.2500 3.1250 143.89%
1998 1.3727 1.0313 3.0000 0.9688 1.2813 64.00%
1997 1.1443 1.2188 1.7500 0.7188 0.7813 -34.21%
1996 1.1455 1.0625 1.6250 0.5000 1.1875 5.56%
1995 1.7764 1.8750 3.0625 1.0000 1.1250 -35.71%
1994 4.1901 7.0000 8.0000 1.7500 1.7500 -74.55%
1993 7.2480 9.5000 10.5000 5.5000 6.8750 -27.63%
1992 12.7505 17.0000 20.1250 8.0000 9.5000 -38.71%
1991 14.3414 12.0000 29.0000 10.3750 15.5000 24.00%
1990 10.6116 10.0000 17.2500 5.0000 12.5000 25.00%
1989 8.2705 7.2500 10.2500 6.2500 10.0000 42.86%
1988 7.5481 8.5000 11.2500 5.2500 7.0000 -12.50%
1987 14.8869 9.0000 26.0000 5.7500 8.0000 -8.57%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.881B $0.634B
Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the sale of several products, which can be categorized mainly under three segments, namely Filtration, Chromatography and Protein products. The chromatography products include OPUS and OPUS PD chromatography columns, chromatography resins and ELISA test kits. Filtration products consist of XCell Alternating Tangential Flow (ATF) Systems and consumables, KrosFlo filtration products and SIUS filtration products. Protein products comprise the Protein A ligands and cell culture growth factors.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $247.799B 18.08
Amgen (AMGN) United States $154.892B 13.19
Gilead Sciences (GILD) United States $140.174B 14.60
Vertex Pharmaceuticals (VRTX) United States $100.254B 25.84
Bristol Myers Squibb (BMY) United States $96.032B 7.01
GSK (GSK) United Kingdom $80.799B 9.40
CSL (CSLLY) Australia $67.141B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.547B 14.97
Alnylam Pharmaceuticals (ALNY) United States $58.528B 0.00
Argenex SE (ARGX) Netherlands $43.587B 76.66
Insmed (INSM) United States $28.768B 0.00
BioNTech SE (BNTX) Germany $24.040B 0.00
Royalty Pharma (RPRX) United States $20.983B 8.20
Biogen (BIIB) United States $19.385B 8.26
Incyte (INCY) United States $16.522B 21.05
Genmab (GNMSF) Denmark $16.469B 14.59
Genmab (GMAB) Denmark $15.956B 14.54
Illumina (ILMN) United States $15.364B 24.03
Ascendis Pharma (ASND) Denmark $11.891B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.189B 15.79
Swedish Orphan Biovitrum (BIOVF) Sweden $10.879B 24.06
QIAGEN (QGEN) Netherlands $10.337B 19.82
Exelixis (EXEL) United States $10.074B 18.17
Moderna (MRNA) United States $9.373B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.161B 0.00
Exact Sciences (EXAS) United States $8.978B 0.00
Bio-Techne Corp (TECH) United States $8.564B 31.58
Halozyme Therapeutics (HALO) United States $8.556B 15.05
Guardant Health (GH) United States $8.408B 0.00
Roivant Sciences (ROIV) United Kingdom $8.147B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.749B 41.34
Revolution Medicines (RVMD) United States $7.098B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.851B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Anbio Biotechnology (NNNN) Germany $6.481B 0.00
Legend Biotech (LEGN) United States $6.410B 0.00
Abivax SA (ABVX) France $6.124B 0.00
Axsome Therapeutics (AXSM) United States $6.052B 0.00
Avidity Biosciences (RNA) United States $5.993B 0.00
Nuvalent (NUVL) United States $5.522B 0.00
Merus (MRUS) Netherlands $4.980B 0.00
Zealand Pharma (ZLDPF) Denmark $4.887B 4.83
Alkermes (ALKS) Ireland $4.782B 13.29
CRISPR Therapeutics AG (CRSP) Switzerland $4.714B 0.00
TG Therapeutics (TGTX) United States $4.654B 79.27
ACADIA Pharmaceuticals (ACAD) United States $4.385B 40.61
Krystal Biotech (KRYS) United States $4.275B 30.02
Cytokinetics (CYTK) United States $4.227B 0.00
Jyong Biotech (MENS) Taiwan $4.167B 0.00
ADMA Biologics Inc (ADMA) United States $4.119B 29.76
Vaxcyte (PCVX) United States $3.997B 0.00
Ascentage Pharma Group - (AAPG) China $3.948B 0.00
PTC Therapeutics (PTCT) United States $3.919B 6.51
Arcellx (ACLX) United States $3.848B 0.00
Akero Therapeutics (AKRO) United States $3.738B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.711B 0.00
Metsera (MTSR) United States $3.707B 0.00
Zai Lab (ZLAB) China $3.699B 0.00
Protagonist Therapeutics (PTGX) United States $3.674B 84.36
MoonLake Immunotherapeutics (MLTX) Switzerland $3.581B 0.00
Apellis Pharmaceuticals (APLS) United States $3.482B 0.00
Telix Pharmaceuticals (TLX) Australia $3.232B 0.00
Ligand Pharmaceuticals (LGND) United States $3.169B 0.00
Scholar Rock Holding (SRRK) United States $3.139B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.046B 0.00
Viking Therapeutics (VKTX) United States $3.042B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.985B 0.00
Kymera Therapeutics (KYMR) United States $2.946B 0.00
Bavarian Nordic (BVNRY) Denmark $2.913B 14.15
Ultragenyx Pharmaceutical (RARE) United States $2.887B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.618B 0.00
Immunovant (IMVT) United States $2.561B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.482B 837.25
Tarsus Pharmaceuticals (TARS) United States $2.473B 0.00
Alvotech (ALVO) Luxembourg $2.433B 18.34
Liquidia Technologies (LQDA) United States $2.383B 0.00
Amicus Therapeutics (FOLD) United States $2.340B 0.00
Denali Therapeutics (DNLI) United States $2.233B 0.00
ImmunityBio (IBRX) United States $2.212B 0.00
Agios Pharmaceuticals (AGIO) United States $2.191B 0.00
Celcuity (CELC) United States $2.174B 0.00
IDEAYA Biosciences (IDYA) United States $2.152B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.122B 11.90
Disc Medicine (IRON) United States $2.074B 0.00
CG Oncology (CGON) United States $2.045B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.041B 0.00
ANI Pharmaceuticals (ANIP) United States $2.029B 18.19
Adaptive Biotechnologies (ADPT) United States $2.007B 0.00
Belite Bio (BLTE) United States $2.007B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.861B 0.00
Vericel (VCEL) United States $1.835B 303.00
Sarepta Therapeutics (SRPT) United States $1.778B 0.00
Mesoblast (MESO) Australia $1.770B 0.00
Certara (CERT) United States $1.741B 31.88
Apogee Therapeutics (APGE) United States $1.677B 0.00
Cidara Therapeutics (CDTX) United States $1.658B 0.00
Beam Therapeutics (BEAM) United States $1.655B 0.00
Biohaven (BHVN) United States $1.628B 0.00
Twist Bioscience (TWST) United States $1.628B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.623B 0.00
Travere Therapeutics (TVTX) United States $1.560B 0.00
WAVE Life Sciences (WVE) Singapore $1.528B 0.00
Edgewise Therapeutics (EWTX) United States $1.512B 0.00
Viridian Therapeutics (VRDN) United States $1.501B 0.00
Celldex Therapeutics (CLDX) United States $1.466B 0.00
MannKind (MNKD) United States $1.408B 41.73
Syndax Pharmaceuticals (SNDX) United States $1.407B 0.00
Vera Therapeutics (VERA) United States $1.381B 0.00
NovoCure (NVCR) Jersey $1.378B 0.00
Cogent Biosciences (COGT) United States $1.375B 0.00
Janux Therapeutics (JANX) United States $1.365B 0.00
Precigen (PGEN) United States $1.344B 0.00
89BIO (ETNB) United States $1.339B 0.00
AbCellera Biologics (ABCL) Canada $1.249B 0.00
Intellia Therapeutics (NTLA) United States $1.219B 0.00
Novavax (NVAX) United States $1.213B 3.28
CureVac (CVAC) Germany $1.205B 5.59
Pacira BioSciences (PCRX) United States $1.198B 12.70
Dynavax Technologies (DVAX) United States $1.187B 50.60
GRAIL (GRAL) United States $1.182B 0.00
NeoGenomics (NEO) United States $1.134B 0.00
Pharvaris (PHVS) Netherlands $1.132B 0.00
Arcus Biosciences (RCUS) United States $1.127B 0.00
Zymeworks (ZYME) United States $1.113B 0.00
Structure Therapeutics (GPCR) United States $1.112B 0.00
CorMedix Inc (CRMD) United States $1.107B 19.77
LENZ Therapeutics (LENZ) United States $1.102B 0.00
Sionna Therapeutics (SION) United States $1.087B 0.00
Stoke Therapeutics (STOK) United States $1.083B 23.25
MiMedx (MDXG) United States $1.051B 23.67
Mineralys Therapeutics (MLYS) United States $1.026B 0.00
Pharming Group (PHAR) Netherlands $1.021B 0.00
Nuvation Bio (NUVB) United States $1.017B 0.00
Spyre Therapeutics (SYRE) United States $0.996B 0.00
Oric Pharmaceuticals (ORIC) United States $0.994B 0.00
Praxis Precision Medicines (PRAX) United States $0.958B 0.00
Upstream Bio (UPB) United States $0.923B 0.00
Urogen Pharma (URGN) United States $0.900B 0.00
UniQure (QURE) Netherlands $0.896B 0.00
Fortrea Holdings (FTRE) United States $0.894B 15.89
Geron (GERN) United States $0.893B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Trevi Therapeutics (TRVI) United States $0.883B 0.00
Pharming Group (PHGUF) Netherlands $0.872B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.864B 0.00
Anavex Life Sciences (AVXL) United States $0.828B 0.00
Immunome (IMNM) United States $0.828B 0.00
Iovance Biotherapeutics (IOVA) United States $0.807B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.797B 0.00
Niagen Bioscience (NAGE) United States $0.790B 76.15
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
ArriVent BioPharma (AVBP) United States $0.776B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.769B 0.00
Dianthus Therapeutics (DNTH) United States $0.759B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.750B 0.00
Tango Therapeutics (TNGX) United States $0.747B 0.00
Gyre Therapeutics (GYRE) United States $0.745B 154.80
BGM Group (BGM) China $0.730B 0.00
Sana Biotechnology (SANA) United States $0.728B 0.00
Nurix Therapeutics (NRIX) United States $0.714B 0.00
Arbutus Biopharma (ABUS) United States $0.711B 0.00
Oculis Holding AG (OCS) Switzerland $0.704B 0.00
GH Research (GHRS) Ireland $0.702B 0.00
Castle Biosciences (CSTL) United States $0.696B 68.60
Vir Biotechnology (VIR) United States $0.686B 0.00
Kura Oncology (KURA) United States $0.686B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.676B 0.00
Tyra Biosciences (TYRA) United States $0.675B 0.00
Zenas BioPharma (ZBIO) United States $0.674B 0.00
Bicara Therapeutics (BCAX) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Rapport Therapeutics (RAPP) United States $0.643B 0.00
Maze Therapeutics (MAZE) United States $0.635B 0.00
Rezolute (RZLT) United States $0.619B 0.00
Immatics (IMTX) Germany $0.619B 0.00
Keros Therapeutics (KROS) United States $0.618B 49.06
Terns Pharmaceuticals (TERN) United States $0.609B 0.00
Palvella Therapeutics (PVLA) United States $0.599B 0.00
Myriad Genetics (MYGN) United States $0.593B 0.00
Inventiva S.A (IVA) France $0.592B 0.00
MeiraGTx Holdings (MGTX) United States $0.587B 0.00
Opthea (OPT) Australia $0.583B 0.00
Verastem (VSTM) United States $0.569B 0.00
AnaptysBio (ANAB) United States $0.569B 0.00
Arvinas (ARVN) United States $0.568B 0.00
Gossamer Bio (GOSS) United States $0.562B 0.00
Septerna (SEPN) United States $0.539B 0.00
ATyr Pharma (ATYR) United States $0.527B 0.00
Cytek Biosciences (CTKB) United States $0.527B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.511B 0.00
MBX Biosciences (MBX) United States $0.507B 0.00
Alumis (ALMS) United States $0.483B 0.00
Compass Therapeutics (CMPX) United States $0.483B 0.00
Tectonic Therapeutic (TECX) United States $0.478B 0.00
Kodiak Sciences (KOD) United States $0.478B 0.00
Eton Pharmaceuticals (ETON) United States $0.464B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.462B 0.00
REGENXBIO (RGNX) United States $0.451B 0.00
Northwest Biotherapeutics (NWBO) United States $0.449B 0.00
ITeos Therapeutics (ITOS) United States $0.449B 0.00
Cullinan Therapeutics (CGEM) United States $0.445B 0.00
Erasca (ERAS) United States $0.445B 0.00
Emergent Biosolutions (EBS) United States $0.443B 3.62
Zhengye Biotechnology Holding (ZYBT) China $0.441B 0.00
Prothena (PRTA) Ireland $0.441B 0.00
Prime Medicine (PRME) United States $0.436B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.428B 0.00
Solid Biosciences (SLDB) United States $0.427B 0.00
Replimune (REPL) United States $0.422B 0.00
PureTech Health (PRTC) United States $0.412B 0.00
Inhibrx Biosciences (INBX) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.400B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.399B 0.00
Kamada (KMDA) Israel $0.398B 20.35
XOMA Royalty (XOMA) United States $0.392B 0.00
Aura Biosciences (AURA) United States $0.389B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.389B 0.00
Olema Pharmaceuticals (OLMA) United States $0.375B 0.00
Absci (ABSI) United States $0.357B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.354B 0.00
Fulcrum Therapeutics (FULC) United States $0.351B 0.00
Abeona Therapeutics (ABEO) United States $0.350B 7.42
Astria Therapeutics (ATXS) United States $0.349B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.345B 0.00
I-Mab (IMAB) United States $0.340B 0.00
CytomX Therapeutics (CTMX) United States $0.336B 3.64
Candel Therapeutics (CADL) United States $0.318B 0.00
Design Therapeutics (DSGN) United States $0.315B 0.00
Amarin (AMRN) Ireland $0.311B 0.00
Ocugen (OCGN) United States $0.298B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.296B 13.33
DiaMedica Therapeutics (DMAC) United States $0.295B 0.00
ScPharmaceuticals (SCPH) United States $0.293B 0.00
Contineum Therapeutics (CTNM) United States $0.293B 0.00
Foghorn Therapeutics (FHTX) United States $0.286B 0.00
Lifecore Biomedical (LFCR) United States $0.285B 0.00
Crescent Biopharma (CBIO) United States $0.282B 0.00
Tvardi Therapeutics (TVRD) United States $0.281B 0.00
Neumora Therapeutics (NMRA) United States $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.279B 0.00
Bright Minds Biosciences (DRUG) United States $0.274B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.272B 0.00
Atea Pharmaceuticals (AVIR) United States $0.267B 0.00
DBV Technologies S.A (DBVT) France $0.264B 0.00
Neurogene (NGNE) United States $0.264B 0.00
Cartesian Therapeutics (RNAC) United States $0.261B 0.00
Jade Biosciences (JBIO) United States $0.258B 0.00
Puma Biotechnology (PBYI) United States $0.254B 5.14
Allogene Therapeutics (ALLO) United States $0.251B 0.00
Vor Biopharma (VOR) $0.250B 0.00
Adherex Technologies (FENC) United States $0.247B 0.00
Codexis (CDXS) United States $0.246B 0.00
Humacyte (HUMA) United States $0.245B 0.00
Sagimet Biosciences (SGMT) United States $0.244B 0.00
Alector (ALEC) United States $0.238B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.237B 0.00
Prima BioMed (IMMP) Australia $0.236B 0.00
EnGene Holdings (ENGN) Canada $0.236B 0.00
Alpha Teknova (TKNO) United States $0.231B 0.00
Editas Medicine (EDIT) United States $0.231B 0.00
Annexon (ANNX) United States $0.226B 0.00
Adocia (ADOCY) France $0.216B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.211B 0.00
Monopar Therapeutics (MNPR) United States $0.211B 0.00
Immuneering (IMRX) United States $0.209B 0.00
Entrada Therapeutics (TRDA) United States $0.208B 0.00
AC Immune (ACIU) Switzerland $0.205B 0.00
SELLAS Life Sciences (SLS) United States $0.202B 0.00
GENFIT S.A (GNFT) France $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.193B 0.00
Rapt Therapeutics (RAPT) United States $0.188B 0.00
Voyager Therapeutics (VYGR) United States $0.186B 0.00
C4 Therapeutics (CCCC) United States $0.185B 0.00
Tenaya Therapeutics (TNYA) United States $0.184B 0.00
Instil Bio (TIL) United States $0.182B 0.00
Aardvark Therapeutics (AARD) United States $0.180B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.180B 0.00
Tevogen Bio Holdings (TVGN) United States $0.179B 0.00
Cognition Therapeutics (CGTX) United States $0.179B 0.00
BioAge Labs (BIOA) United States $0.177B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.174B 0.00
Elicio Therapeutics (ELTX) United States $0.172B 0.00
Ventyx Biosciences (VTYX) United States $0.171B 0.00
Citius Oncology (CTOR) United States $0.170B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.169B 0.00
Nuvectis Pharma (NVCT) United States $0.167B 0.00
Seres Therapeutics (MCRB) United States $0.166B 0.00
Kyverna Therapeutics (KYTX) United States $0.160B 0.00
Sangamo Therapeutics (SGMO) United States $0.157B 0.00
Black Diamond Therapeutics (BDTX) United States $0.157B 11.96
Greenwich LifeSciences (GLSI) United States $0.156B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.156B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.151B 0.00
Climb Bio (CLYM) United States $0.151B 0.00
Nkarta (NKTX) United States $0.151B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
MaxCyte (MXCT) United States $0.148B 0.00
Cellectis S.A (CLLS) France $0.143B 0.00
Cardiff Oncology (CRDF) United States $0.140B 0.00
Forte Biosciences (FBRX) United States $0.137B 0.00
Anika Therapeutics (ANIK) United States $0.135B 0.00
TuHURA Biosciences (HURA) United States $0.135B 0.00
Coherus Oncology (CHRS) United States $0.135B 0.00
BioHarvest Sciences (BHST) Canada $0.134B 0.00
Alpha Cognition (ACOG) Canada $0.134B 0.00
Agenus (AGEN) United States $0.133B 0.00
Zura Bio (ZURA) United States $0.133B 0.00
Cabaletta Bio (CABA) United States $0.133B 0.00
Inovio Pharmaceuticals (INO) United States $0.126B 0.00
Compugen (CGEN) Israel $0.126B 0.00
Genelux (GNLX) United States $0.126B 0.00
Scilex Holding (SCLX) United States $0.124B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.122B 0.00
Fate Therapeutics (FATE) United States $0.120B 0.00
BioStem Technologies (BSEM) $0.119B 6.23
Invivyd (IVVD) United States $0.117B 0.00
Spero Therapeutics (SPRO) United States $0.116B 0.00
Biomea Fusion (BMEA) United States $0.116B 0.00
Seer (SEER) United States $0.116B 0.00
Connect Biopharma Holdings (CNTB) United States $0.115B 0.00
Coya Therapeutics (COYA) United States $0.110B 0.00
Skye Bioscience (SKYE) United States $0.108B 0.00
InflaRx (IFRX) Germany $0.107B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.106B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Oncolytics Biotech (ONCY) Canada $0.104B 0.00
23andMe Holding (MEHCQ) United States $0.104B 0.00
Equillium (EQ) United States $0.104B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.103B 0.00
VistaGen Therapeutics (VTGN) United States $0.102B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Pliant Therapeutics (PLRX) United States $0.101B 0.00
Adagene (ADAG) China $0.100B 0.00
Alto Neuroscience (ANRO) United States $0.100B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
Elutia (ELUT) United States $0.097B 0.00
XBiotech (XBIT) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Celularity (CELU) United States $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.091B 0.00
CervoMed (CRVO) United States $0.089B 0.00
OKYO Pharma (OKYO) $0.088B 0.00
Entera Bio (ENTX) Israel $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Nautilus Biotechnology (NAUT) United States $0.086B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.082B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Immunic (IMUX) United States $0.081B 0.00
KALA BIO (KALA) United States $0.079B 0.00
Artiva Biotherapeutics (ARTV) United States $0.077B 0.00
Fortress Biotech (FBIO) United States $0.077B 0.00
Kalaris Therapeutics (KLRS) United States $0.076B 0.00
Opus Genetics (IRD) United States $0.073B 0.00
Sutro Biopharma (STRO) United States $0.073B 0.00
Repare Therapeutics (RPTX) Canada $0.072B 0.00
Applied Therapeutics (APLT) United States $0.071B 0.00
TELA Bio (TELA) United States $0.071B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.065B 0.00
Aligos Therapeutics (ALGS) United States $0.065B 0.00
BioXcel Therapeutics (BTAI) United States $0.065B 0.00
Adverum Biotechnologies (ADVM) United States $0.065B 0.00
MiNK Therapeutics (INKT) United States $0.064B 0.00
Quantum Biopharma (QNTM) Canada $0.064B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.064B 0.00
Immix Biopharma (IMMX) United States $0.064B 0.00
ALX Oncology Holdings (ALXO) United States $0.063B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Adicet Bio (ACET) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
PDS Biotechnology (PDSB) United States $0.058B 0.00
Precision BioSciences (DTIL) United States $0.058B 0.00
INmune Bio (INMB) United States $0.054B 0.00
ImageneBio (IMA) United States $0.054B 0.00
Clene (CLNN) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Shattuck Labs (STTK) United States $0.047B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.046B 0.00
Jasper Therapeutics (JSPR) United States $0.046B 0.00
Annovis Bio (ANVS) United States $0.045B 0.00
Lantern Pharma (LTRN) United States $0.044B 0.00
Alterity Therapeutics - (ATHE) Australia $0.044B 0.00
Radiopharm Theranostics - (RADX) Australia $0.043B 0.00
X4 Pharmaceuticals (XFOR) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.041B 0.00
Renovaro (RENB) United States $0.041B 0.00
Generation Bio (GBIO) United States $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Senti Biosciences (SNTI) United States $0.038B 0.00
PepGen (PEPG) United States $0.038B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.037B 0.00
Rani Therapeutics Holdings (RANI) United States $0.037B 0.00
Mersana Therapeutics (MRSN) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Exicure (XCUR) United States $0.035B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.035B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
Tharimmune (THAR) United States $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
BioAtla (BCAB) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Passage Bio (PASG) United States $0.023B 0.00
Allarity Therapeutics (ALLR) United States $0.023B 0.00
Rallybio (RLYB) United States $0.022B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.020B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.020B 0.00
Synaptogenix (TAOX) United States $0.020B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.018B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Chemomab Therapeutics (CMMB) Israel $0.015B 0.00
Biorestorative Therapies (BRTX) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
NextCure (NXTC) United States $0.013B 0.00
Soligenix (SNGX) United States $0.013B 0.00
Longeveron (LGVN) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
Femasys (FEMY) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IN8bio (INAB) United States $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Apollomics (APLM) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Entero Therapeutics (ENTO) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
GT Biopharma (GTBP) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00